United Kingdom

People: Allogene Therapeutics Inc (ALLO.OQ)

ALLO.OQ on NASDAQ Stock Exchange Global Select Market

20 Aug 2019
Change (% chg)

$-0.51 (-1.84%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Messemer, Deborah 

Ms. Deborah M. Messemer serves as Independent Director of the Company. Ms. Messemer is a certified public accountant and joined KPMG LLP (KPMG), the U.S. member firm of KPMG International, in 1982 and was admitted into the partnership in 1995. Most recently, Ms. Messemer served as the Managing Partner of KPMG’s Bay Area and Northwest region until July 2018. In that role, she was responsible for leading over 3,000 team members in 10 offices across all functions, including audit, tax and advisory. Ms. Messemer spent the majority of her career in KPMG’s audit practice as an audit engagement partner serving public and private clients in a variety of industry sectors. In addition to audit signing responsibilities, she has significant experience in SEC filings, due diligence, initial public offerings, mergers and acquisitions, and internal controls over financial reporting. Ms. Messemer is a member of the National Association of Corporate Directors and the San Francisco Chapter of Women Corporate Directors. She has served extensively on non-profit and advisory boards including the Bay Area Council, the San Francisco Committee on Jobs, the California Chamber of Commerce, the San Francisco Chamber of Commerce, the UC Berkeley Fisher Center Policy Advisory Board, San Francisco Ballet, and Posse. Ms. Messemer received a bachelor’s degree in accounting from the University of Texas at Arlington. Our board of directors believes Ms. Messemer’s expertise in the accounting and finance industry, her experience advising public companies and her education provide her with the qualifications and skills to serve on our board or directors.

Basic Compensation

Total Annual Compensation, USD 10,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 2,118,900
Fiscal Year Total, USD 2,128,900

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Arie Belldegrun


David Chang


Joshua Kazam


Eric Schmidt


Alison Moore


David Bonderman

As Of  31 Dec 2018